Tech Healthcare Sector

Neurobiological Technologies

Market Cap: US$27.0

Operates under a plan of liquidation and dissolution approved by stockholders in October 2009.

DiaSys

Market Cap: US$25.0

Designs, develops, manufactures, and distributes proprietary medical laboratory equipment, consumables, and test kits to healthcare and veterinary diagnostic laboratories worldwide.

VMT Scientific

Market Cap: US$24.0

Engages in the design, development, testing, and patenting of medical technologies for use in tissue histogenesis.

Verde Science

Market Cap: US$23.0

A pharmaceutical research and development company, focuses on developing a portfolio of cannabinoid based prescription medicines for various medical conditions.

Longport

Market Cap: US$23.0

Develops, manufactures, markets, and sells high resolution ultrasound imaging systems primarily in the United States.

Regnum

Market Cap: US$22.0

Develops and commercializes therapeutics that treat rare and infectious diseases.

Applied Biosciences

Market Cap: US$21.0

Focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas.

VIA Pharmaceuticals

Market Cap: US$20.0

A development stage biotechnology company, focuses on the development of compounds for the treatment of cardiovascular and metabolic diseases.

Corix Bioscience

Market Cap: US$20.0

Provides cannabidiol (CBD) oil for various medicinal purposes.

Genvor

Market Cap: US$20.0

Develops plant-based defense technology designed to help farmers achieve global food security.

Korver

Market Cap: US$17.0

Engages in the design and manufacture of integrated machine controls that are sold to manufacturers of plastic parts for the automotive, household products, and electronics industries worldwide.

Cardiovascular Sciences

Market Cap: US$17.0

Cardiovascular Sciences Inc., a technology company, focuses on the development of medical products.

IR Biosciences Holdings

Market Cap: US$17.0

IR BioSciences Holdings, Inc. operates as a development stage biotechnology company in the United States.

Xcorporeal

Market Cap: US$15.0

Xcorporeal, Inc. is in the process of liquidation and dissolution, pursuant to the plan adopted by board of directors of the company on February 4, 2010.

Hemagen Diagnostics

Market Cap: US$15.0

A biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide.

Tibet Pharmaceuticals

Market Cap: US$14.0

A specialty pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Tibetan medicines.

IMV

Market Cap: US$14.0

Operates as a clinical-stage immuno-oncology company.

NetMed

Market Cap: US$13.0

Netmed, Inc. did not have any significant operations, as of December 31, 2001.

PhaseRx

Market Cap: US$11.0

A biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy.

American Medical Technologies

Market Cap: US$10.0

Develops, manufactures, and markets dental related equipment.

Easy Technologies

Market Cap: US$10.0

Develops an Internet based platform in the online gaming area.

Viveve Medical

Market Cap: US$10.0

Designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence.

ERecord Management

Market Cap: US$9.0

ERecord Management, Inc. operates as a healthcare consulting company.

Vasamed

Market Cap: US$8.0

Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States.

Minerva Surgical

Market Cap: US$8.0

A commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States.

Turbine Aviation

Market Cap: US$8.0

A development stage company, through its subsidiary, H7 Security Systems, Inc., develops and markets homeland security products.

Motus GI Holdings

Market Cap: US$7.0

Operates as a medical technology company in the United States.

Proteonomix

Market Cap: US$7.0

A biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives.

Bionovate Technologies

Market Cap: US$7.0

A medical device company, focuses on developing automated treatment for age spots.

VioQuest Pharmaceuticals

Market Cap: US$6.0

VioQuest Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of clinical stage drug therapies for the treatment of oncology and infectious diseases.

Adynxx

Market Cap: US$5.0

A clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases.

Excellerant

Market Cap: US$5.0

A development stage company, focuses on providing a range of health advisory and tour services to legal entities and individuals.

Speedus

Market Cap: US$4.0

Through its subsidiaries, engages in the development of diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists, and other healthcare professionals in the United States.

Arch Therapeutics

Market Cap: US$4.0

Operates as a biotechnology company in the United States.

Acusphere

Market Cap: US$4.0

Operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs.

Assure Holdings

Market Cap: US$3.0

Through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States.